To include your compound in the COVID-19 Resource Center, submit it here.

Oyster Point, RAPT post gains after pricing IPOs at low end of range

Investors’ appetite for new biotech listings has shown signs of waning this fall, but Oyster Point and RAPT managed to price NASDAQ IPOs within expectations ahead of Thursday’s session, and each posted gains in the early aftermarket.

Both companies sold their proposed numbers of shares at the

Read the full 461 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE